Ricevi le ultime notizie sulle azioni Trevi Therapeutics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di TRVI

Ultime notizie per

TREVI THERAPEUTICS INC

Trevi Therapeutics

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Trevi Therapeutics Inc

Offerings

Press Releases

Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock

Trevi Therapeutics Announces Closing of $115 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

News

Legal

TRVI STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Trevi Therapeutics, Inc. (NASDAQ: TRVI) and Encourages Long-Term Investors to Contact the Firm

Trevi Therapeutics to Attend Leerink Partners Therapeutics Forum: I&I and Metabolism

Trevi Therapeutics to Participate in Upcoming August Conferences

Trevi Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 7, 2025

Earnings

Trevi Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

Trevi Therapeutics to Participate in Upcoming September Conferences

Trevi Therapeutics Announces Two Posters from the Phase 2a RIVER Trial Data Will be Featured at the European Respiratory Society (ERS) Congress 2025

Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting

TRVI

Amylyx Pharmaceuticals, Inc. - Common Stock

Amylyx Pharmaceuticals

Amphastar Pharmaceuticals, Inc. - Common Stock

Amphastar Pharma

ATAI Life Sciences

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical

Cronos Group

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

Edgewise Therapeutics, Inc. - Common Stock

Edgewise Therapeutics

Structure Therapeutics Inc. - American Depositary Shares

Structure Therapeutics

Harmony Biosciences Holdings, Inc. - Common Stock

Harmony Biosciences Hldgs

Harrow

Innoviva

LENZ Therapeutics

Maze Therapeutics

Nektar Therapeutics

Nuvation Bio

Oculis Holding

Phibro Animal Health Corporation - Class A Common Stock

Phibro Animal Health

Pacira BioSciences

Phathom Pharmaceuticals, Inc. - Common Stock

Phathom Pharmaceuticals

Pharvaris

Rapport Therapeutics, Inc. - Common Stock

Rapport Therapeutics

Septerna

Tilray Brands

Wave Life Sciences Ltd. - Ordinary Shares

WAVE Life Sciences

Xeris Biopharma Holdings, Inc. - Common Stock

Comments

Trevi Therapeutics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO